Ibutact (Ibuprofen)

Ibuprofen blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, decreasing the synthesis of prostaglandins that mediate pain, fever, and inflammation. Lower prostaglandin levels reduce peripheral nerve sensitisation, lower the hypothalamic temperature set‑point, and limit inflammatory swelling.

The appropriate dose of ibuprofen is determined by a prescriber based on the patient’s age, weight, clinical condition, and treatment duration. Healthcare professionals select the strength, frequency, and length of therapy that best matches the individual’s therapeutic needs.

Safety of ibuprofen during pregnancy and lactation depends on the trimester and individual risk factors. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare provider, who can weigh potential benefits against possible risks to the fetus or infant.

To request Ibutact, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibuprofen and naproxen belong to the same NSAID class and share similar mechanisms, but ibuprofen generally has a shorter half‑life, leading to more frequent dosing, whereas naproxen provides longer‑lasting pain control with once‑ or twice‑daily dosing. Individual response, safety profile and drug‑interaction potential guide the choice between them.

Ibutact should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain stability and potency throughout its shelf life.

Ibutact is taken orally, with or without food, as directed by a healthcare professional. Swallow tablets or capsules whole with a full glass of water. If an oral liquid form is supplied, use a calibrated measuring device to ensure accurate dosing.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, renal impairment especially with prolonged use, and cardiovascular events in susceptible individuals. Prompt medical attention is required if any of these events are suspected.

Individuals with a known hypersensitivity to ibuprofen or other NSAIDs, active peptic ulcer disease, severe heart failure, uncontrolled hypertension, significant renal or hepatic impairment, and those in the third trimester of pregnancy should avoid ibuprofen unless specifically advised by a physician.